Nutriband Chairman to Present at NobleCon21 Investor Conference

Nutriband Inc. (NASDAQ: NTRB) announced that Chairman and Co-Founder Serguei Melnik will present at NobleCon21, Noble Capital Markets' annual emerging growth equity conference. The presentation is scheduled for December 3 at 9:30 a.m. Eastern Time at Florida Atlantic University's Executive Education Complex in Boca Raton, Florida. This investor conference provides an important platform for emerging growth companies to showcase their business strategies and technological innovations to the investment community.

The company's participation in this significant financial conference matters because it represents a crucial opportunity to communicate Nutriband's progress and potential directly to investors and financial analysts. Investors and guests may attend the conference at a discounted rate using code NTRBNOBLECON, making the event more accessible to current and potential shareholders. For those unable to attend in person, a high-definition webcast will be available the following day at nobleconference.com and Channelchek.com, where it will remain archived for 90 days, ensuring broad accessibility to the investment community.

Nutriband's presentation at this prominent financial conference carries substantial implications for the company's visibility and investor relations strategy. The company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products, with their lead product being an abuse-deterrent fentanyl patch incorporating their proprietary AVERSA technology. This technology platform represents a significant innovation in pharmaceutical safety, as it can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

The importance of this investor presentation extends beyond mere corporate visibility. With the ongoing opioid crisis affecting communities nationwide, Nutriband's AVERSA technology addresses a critical public health challenge by developing safer pharmaceutical delivery systems. The company's focus on abuse-deterrent formulations positions it at the forefront of pharmaceutical innovation aimed at combating prescription drug abuse. Investors can access additional company information through the corporate newsroom at https://nnw.fm/NTRB, providing ongoing updates about the company's development progress and corporate milestones.

NetworkNewsWire, the specialized communications platform distributing this announcement, operates as part of the Dynamic Brand Portfolio that provides comprehensive financial news distribution services. The platform offers access to wire solutions through InvestorWire, article syndication to thousands of outlets, enhanced press release services, and social media distribution to millions of followers. This extensive distribution network ensures that Nutriband's message reaches a wide audience of investors, influencers, and industry professionals, potentially enhancing market awareness and investor engagement with the company's innovative pharmaceutical development programs.